caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1972785608

Dileema Kalansuriya

Internal MedicineSouthbury, CTI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Dileema Kalansuriya's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 7 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Agata Jaskiewicz-Poznanska
Family Practice · Southbury, CT
39148
Casey Ott
Internal Medicine · Southbury, CT
37119
Quest Diagnostics Llc
Clinical Laboratory · Wallingford, CT
2585
Paul Mcguire
Diagnostic Radiology · Danbury, CT
2083
WATERBURY HOSPITAL1340
Seema Bakhru
Diagnostic Radiology · Hartford, CT
1227
Robert Deveney
Orthopedic Surgery · Danbury, CT
1131
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,383
Unique beneficiaries
—
Total services
1,816
Distinct HCPCS
20
Medicare payment
$149K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 1,650 Internal Medicine providers in CT — top quintile (cohort median 549).
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
7,286
Beneficiaries
—
Total drug cost
$723K
Distinct drugs
113
Brand share
20.8%
Top prescribed drugs
Atorvastatin Calcium670 claims
Levothyroxine Sodium426 claims
Amlodipine Besylate374 claims
Lisinopril250 claims
Rosuvastatin Calcium225 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.